Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine-protein kinase FRK, also known as Fyn-related kinase or protein tyrosine kinase 5, is a member of the TYR family of protein kinases encoded by the *FRK* gene in humans. It is a nuclear-localized enzyme that may function during G1 and S phases of the cell cycle to suppress cellular growth. This protein has been shown to interact with retinoblastoma protein and is predominantly expressed in epithelial tissues. As a non-receptor tyrosine kinase, it plays roles in signal transduction pathways regulating cell proliferation and has been studied as a potential tumor suppressor[3][5][6]. Several approved drugs act on this target by inhibiting its enzymatic activity, making it relevant for cancer therapy research[3].
Drugs targeting this molecule generally act as **kinase inhibitors**, blocking the phosphorylation activity of the enzyme, thereby interfering with downstream signaling pathways involved in cell growth and survival[1][2].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine-protein kinase FRK (FRK).